摘要
目的:探讨血浆D-二聚体测定对深静脉血栓形成(DVT)诊断和疗效评估的意义及DVT患者临床危险因素。方法回顾性分析435例DVT患者的血浆D-二聚体水平,同时在体检人群中随机选择150例作为对照组,比较分析DVT患者中135例初诊时的危险因素。进一步监测其中的33例DVT患者治疗后1-3d、7-10d、15d的血浆D-二聚体变化情况。结果 DVT患者血浆D-二聚体水平与对照组相比有统计学差异(P=0.000),抗凝治疗的有效率为78.8%。治疗有效组DVT患者的血浆D-二聚体下降程度与无效组相比有统计学差异(P=0.005)。年龄<40岁的DVT患者中手术和外伤是主要危险因素,而年龄≥40岁患者中肿瘤、内科疾病、中心静脉置管及长期卧床是其主要危险因素。结论血浆D-二聚体是DVT诊断及疗效评估的重要指标,DVT危险因素是其一级预防的依据。
Objective To investigate plasma D- dimer levels in patients with deep venous thrombosis (DVT). Methods Plasma D- dimer levels were measured in 435 patients with DVT, and 150 healthy subjects (controls). The clinical data and plas-ma D- dimer levels were retrospectively analyzed in 135 DVT patients and the D- dimer levels were monitored in 33 DVT patients during the anticoagulation therapy at different time points (at 1-3d, 7-10d and 15d). Results Compared to healthy subjects, plasma D- dimer levels in DVT patients were significantly increased (P=0.000). The overal effective rate of treatment was 78.8%, D- dimer levels in effective patientws was significantly decreased after treatment (P=0.005). For patients aged〈40, surgery and trauma were major risk factors of DVT;for those aged≥40, medical diseases, cancer, placement of central venous catheter and long- term bed rest were major risk factors. Conclusion Measurement of plasma D- dimer levels is of value in diagnosis and monotoring of therapeutic effect for patients with deep vein thrombosis.
出处
《浙江医学》
CAS
2013年第22期1985-1988,共4页
Zhejiang Medical Journal
基金
杭州市科技局项目(20080333B09)